137 related articles for article (PubMed ID: 11328664)
81. Uptake studies for evaluating activity of efflux transporters in a cell line representative of the blood-brain barrier.
Silverstein PS; Karunaratne DN; Audus KL
Curr Protoc Pharmacol; 2004 Feb; Chapter 7():Unit7.7. PubMed ID: 21956812
[TBL] [Abstract][Full Text] [Related]
82. Blood-brain-barrier transport of lipid microspheres containing clinprost, a prostaglandin I2 analogue.
Minagawa T; Sakanaka K; Inaba S; Sai Y; Tamai I; Suwa T; Tsuji A
J Pharm Pharmacol; 1996 Oct; 48(10):1016-22. PubMed ID: 8953502
[TBL] [Abstract][Full Text] [Related]
83. Examining the Uptake of Central Nervous System Drugs and Candidates across the Blood-Brain Barrier.
Summerfield SG; Zhang Y; Liu H
J Pharmacol Exp Ther; 2016 Aug; 358(2):294-305. PubMed ID: 27194478
[TBL] [Abstract][Full Text] [Related]
84. Stereoselective blood-brain barrier transport of histidine in rats.
Yamakami J; Sakurai E; Sakurada T; Maeda K; Hikichi N
Brain Res; 1998 Nov; 812(1-2):105-12. PubMed ID: 9813265
[TBL] [Abstract][Full Text] [Related]
85. The effect of endothelins on ion transport systems in cultured rat brain capillary endothelial cells.
Kawai N; McCarron RM; Spatz M
Acta Neurochir Suppl; 1997; 70():138-40. PubMed ID: 9416302
[TBL] [Abstract][Full Text] [Related]
86. In vivo delivery of small interfering RNA targeting brain capillary endothelial cells.
Hino T; Yokota T; Ito S; Nishina K; Kang YS; Mori S; Hori S; Kanda T; Terasaki T; Mizusawa H
Biochem Biophys Res Commun; 2006 Feb; 340(1):263-7. PubMed ID: 16364250
[TBL] [Abstract][Full Text] [Related]
87. Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.
Syvänen S; Xie R; Sahin S; Hammarlund-Udenaes M
Pharm Res; 2006 Apr; 23(4):705-17. PubMed ID: 16575498
[TBL] [Abstract][Full Text] [Related]
88. Brain-to-blood active transport of beta-alanine across the blood-brain barrier.
Komura J; Tamai I; Senmaru M; Terasaki T; Sai Y; Tsuji A
FEBS Lett; 1997 Jan; 400(1):131-5. PubMed ID: 9000528
[TBL] [Abstract][Full Text] [Related]
89. Evaluation of blood-brain barrier transporters by co-culture of brain capillary endothelial cells with astrocytes.
Kido Y; Tamai I; Nakanishi T; Kagami T; Hirosawa I; Sai Y; Tsuji A
Drug Metab Pharmacokinet; 2002; 17(1):34-41. PubMed ID: 15618650
[TBL] [Abstract][Full Text] [Related]
90. Correlation between quinolone uptakes by BCECs in vitro and brain-to-plasma concentration ratios in rats.
Liu XD; Wang DW; Xie L
Eur J Drug Metab Pharmacokinet; 2005; 30(4):249-54. PubMed ID: 16435569
[TBL] [Abstract][Full Text] [Related]
91. The effect of protein binding on ivermectin uptake by bovine brain microvessel endothelial cells.
Audus KL; Knaub SR; Guillot FL; Schaeffer JM
Vet Res Commun; 1992; 16(5):365-77. PubMed ID: 1494861
[TBL] [Abstract][Full Text] [Related]
92. On the mechanism and dynamics of uptake and permeation of polyether-copolyester dendrimers across an in vitro blood-brain barrier model.
Dhanikula RS; Hammady T; Hildgen P
J Pharm Sci; 2009 Oct; 98(10):3748-60. PubMed ID: 19156840
[TBL] [Abstract][Full Text] [Related]
93. Investigation on the influx transport mechanism of pentazocine at the blood-brain barrier in rats using the carotid injection technique.
Suzuki T; Moriki Y; Goto H; Tomono K; Hanano M; Watanabe J
Biol Pharm Bull; 2002 Oct; 25(10):1351-5. PubMed ID: 12392093
[TBL] [Abstract][Full Text] [Related]
94. Fluid-phase endocytosis by primary cultures of bovine brain microvessel endothelial cell monolayers.
Guillot FL; Audus KL; Raub TJ
Microvasc Res; 1990 Jan; 39(1):1-14. PubMed ID: 2314302
[TBL] [Abstract][Full Text] [Related]
95. Involvement of a Novel Organic Cation Transporter in Paeonol Transport Across the Blood-Brain Barrier.
Gyawali A; Krol S; Kang YS
Biomol Ther (Seoul); 2019 May; 27(3):290-301. PubMed ID: 30971062
[TBL] [Abstract][Full Text] [Related]
96. Blood-brain barrier permeation: molecular parameters governing passive diffusion.
Fischer H; Gottschlich R; Seelig A
J Membr Biol; 1998 Oct; 165(3):201-11. PubMed ID: 9767674
[TBL] [Abstract][Full Text] [Related]
97. Permeability of the developing and mature blood-brain barriers to theophylline in rats.
Habgood MD; Knott GW; Dziegielewska KM; Saunders NR
Clin Exp Pharmacol Physiol; 1998 May; 25(5):361-8. PubMed ID: 9612664
[TBL] [Abstract][Full Text] [Related]
98. A Critical Review of Physicochemical Properties and Analytical Methods Applied to Quantitative Determination of Ebastine.
Frare RG; Singh AK
Crit Rev Anal Chem; 2018 Mar; 48(2):102-109. PubMed ID: 29235880
[TBL] [Abstract][Full Text] [Related]
99. Saturable transport of the neurokinin-1 non-peptide antagonist LY303870 across the rat blood-brain barrier after intravenous administration.
Banks WA; McMillian CL; Iyengar S
Life Sci; 2001 Aug; 69(14):1683-9. PubMed ID: 11589508
[TBL] [Abstract][Full Text] [Related]
100. Biochemical characteristics of a primary blood-brain barrier cell culture system as a function of the activity of the proteases used in tissue disaggregation.
Ng KY; Schallenkemp JM
J Neurosci Methods; 1996 Sep; 68(1):49-53. PubMed ID: 8884612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
